Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03102606
Title Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy (Protective-1)
Acronym Protective-1
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeyondSpring Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.